MicroRNA as novel biomarkers and therapeutic targets in diabetic kidney disease: An update
Abstract Diabetic kidney disease (DKD) is a life‐limiting condition characterized by progressive and irreversible loss of renal function. Currently, the estimated glomerular filtration rate (eGFR) and albuminuria are used as key markers to define DKD. However, they may not accurately indicate the de...
Main Authors: | Qinghua Cao, Xin‐Ming Chen, Chunling Huang, Carol A. Pollock |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-06-01
|
Series: | FASEB BioAdvances |
Subjects: | |
Online Access: | https://doi.org/10.1096/fba.2018-00064 |
Similar Items
-
MicroRNAs as Biomarkers and Therapeutic Targets in Inflammation- and Ischemia-Reperfusion-Related Acute Renal Injury
by: Yueh-Lin Wu, et al.
Published: (2020-09-01) -
MicroRNAs in renal fibrosis
by: Arthur Chi-Kong Chung, et al.
Published: (2015-02-01) -
microRNA Crosstalk Influences Epithelial-to-Mesenchymal, Endothelial-to-Mesenchymal, and Macrophage-to-Mesenchymal Transitions in the Kidney
by: Swayam Prakash Srivastava, et al.
Published: (2019-08-01) -
MicroRNAs in Chronic Kidney Disease: Four Candidates for Clinical Application
by: Linsey J. F. Peters, et al.
Published: (2020-09-01) -
Uromodulin and microRNAs in Kidney Transplantation—Association with Kidney Graft Function
by: Špela Borštnar, et al.
Published: (2020-08-01)